AkzoNobel publishes results for Q2 2024
Highlights Q2 2024 (compared with Q2 2023)
- Organic sales up 2%, with volumes up 1%; Revenue up 2%
- Operating income €270 million (2023: €279 million)
- Adjusted EBITDA €400 million (2023: €397 million); Adjusted EBITDA margin 14.4% (2023: 14.5%)
- Net cash from operating activities positive €151 million (2023: positive €305 million)
Highlights half-year 2024 (compared with half-year 2023)
- Organic sales up 2%, driven by higher volumes and positive price/mix; revenue flat
- Operating income €531 million (2023: €461 million)
- Adjusted EBITDA €763 million (2023: €702 million); Adjusted EBITDA margin 14.1% (2023: 13.0%)
- Net cash from operating activities negative €19 million (2023: positive €255 million)
Outlook
Based on current market conditions and constant currencies, AkzoNobel expects to deliver 2024 adjusted EBITDA towards the lower end of its full-year guidance range of €1.5 to €1.65 billion.
AkzoNobel